Medical Research
(H300)
IRS Verified
DX Registered
990 on File
INSTITUTE FOR CANCER RESEARCH
Financial strength (30%)
83/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
To prevail over cancer, marshalling heart and mind in bold scientific discovery, pioneering prevention and compassionate care.
Financial Overview — FY 2023
$98.8M
Total Revenue
$90.5M
Total Expenses
$108.4M
Net Assets
717
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
66.6%
Fundraising Efficiency
N/A
Operating Reserve
14.38x
Liability-to-Asset
34.0%
Revenue Diversification
55.2%
Executive Compensation
$114K
Compared with Peers
FY 2023
Compared with 132 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
66.6% | 82.7% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
30.3% | 13.5% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
3.1% | 0.0% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
14.4 mo | 12.6 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
34.0% | 29.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
55.2% | 91.9% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
0.6% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
0.7% | 10.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
8.4% | -2.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $98.8M | $90.5M | $108.4M | 66.6% | 717 |
| 2022 | $98.2M | $89.8M | $98.3M | 70.0% | 704 |
| 2021 | $82.6M | $82.7M | N/A | — | 712 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.